BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9144879)

  • 1. Detection of vital germ cell tumor cells in short-term cell cultures of primary tumors and of retroperitoneal metastasis--clinical implications.
    Otto T; Virchow S; Fuhrmann C; Steinberg F; Streffer C; Goepel M; Rübben H
    Urol Res; 1997; 25(2):121-4. PubMed ID: 9144879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors].
    Müller-Mattheis V; Reinhardt M; Gerharz CD; Fürst G; Vosberg H; Müller-Gärtner HW; Ackermann R
    Urologe A; 1998 Nov; 37(6):609-20. PubMed ID: 9887489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of marker half-life during chemotherapy in non-seminomatous germ cell testicular tumors.
    Inanç SE; Meral R; Darendeliler E; Yasasever V; Onat H
    Acta Oncol; 1999; 38(4):505-9. PubMed ID: 10418719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in metastatic nonseminomatous germ cell tumours.
    Hanson PR; Belitsky P; Millard OH; Lannon SG
    Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular localization of alpha-fetoprotein and human chorionic gonadotropin in germ cell tumors of the testis using and indirect immunoperoxidase technique.
    Kurman RJ; Scardino PT; McIntire KR; Waldmann TA; Javadpour N
    Cancer; 1977 Nov; 40(5):2136-51. PubMed ID: 72596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-seminomatous germ cell tumors of the testis. Analysis of AFP and HCG production by primary tumors and retroperitoneal lymph node metastases after PVB combination chemotherapy.
    Suurmeijer AJ; Oosterhuis JW; Marrink J; De Bruin HW; Schraffordt Koops H; Sleijfer DT; Fleuren GJ
    Oncodev Biol Med; 1983; 4(4):289-308. PubMed ID: 6188132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups.
    Steyerberg EW; Keizer HJ; Fosså SD; Sleijfer DT; Toner GC; Schraffordt Koops H; Mulders PF; Messemer JE; Ney K; Donohue JP
    J Clin Oncol; 1995 May; 13(5):1177-87. PubMed ID: 7537801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
    Beck SD; Foster RS; Bihrle R; Donohue JP
    Urology; 2007 Mar; 69(3):557-9. PubMed ID: 17382165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonpalpable testicular pure seminoma with elevated serum alpha-fetoprotein presenting with retroperitoneal metastasis: a case report.
    Iwatsuki S; Naiki T; Kawai N; Etani T; Iida K; Ando R; Nagai T; Okada A; Tozawa K; Sugiyama Y; Yasui T
    J Med Case Rep; 2016 May; 10(1):114. PubMed ID: 27150447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy.
    Mazumdar M; Bajorin DF; Bacik J; Higgins G; Motzer RJ; Bosl GJ
    J Clin Oncol; 2001 May; 19(9):2534-41. PubMed ID: 11331333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rete testis invasion by malignant germ cell tumor and/or intratubular germ cell neoplasia: what is the significance of this finding?
    Vogt AP; Chen Z; Osunkoya AO
    Hum Pathol; 2010 Sep; 41(9):1339-44. PubMed ID: 20573373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of early serum tumor marker half-life in metastatic testicular teratoma.
    Stevens MJ; Norman AR; Dearnaley DP; Horwich A
    J Clin Oncol; 1995 Jan; 13(1):87-92. PubMed ID: 7528272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the M371-Test Under Real-life Conditions for Diagnosis and Follow Up of Testicular Germ Cell Tumors.
    Pycha S; D'Elia C; Mian C; Schwienbacher C; Hanspeter E; Palermo M; Pycha A; Danuser H; Trenti E
    Anticancer Res; 2023 Apr; 43(4):1649-1653. PubMed ID: 36974797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 10-year retrospective single-center study of alpha-fetoprotein and beta-human chorionic gonadotropin in Romanian children with (para)gonadal tumors and cysts.
    Ataikiru UO; Iacob ER; Miron I; Popoiu CM; Boia ES
    J Pediatr Endocrinol Metab; 2022 Mar; 35(3):363-371. PubMed ID: 34968016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum human chorionic gonadotropin is associated with angiogenesis in germ cell testicular tumors.
    Arrieta O; Michel Ortega RM; Angeles-Sánchez J; Villarreal-Garza C; Avilés-Salas A; Chanona-Vilchis JG; Aréchaga-Ocampo E; Luévano-González A; Jiménez MA; Aguilar JL
    J Exp Clin Cancer Res; 2009 Aug; 28(1):120. PubMed ID: 19709439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AFP and HCG in germ cell tumors.
    Bassetto MA; Franceschi T; Lenotti M; Parise G; Pancheri F; Sabbioni R; Zaninelli M; Cetto GL
    Int J Biol Markers; 1994; 9(1):29-32. PubMed ID: 7519651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of AFP and HCG in metastatic testicular cancer after treatment with chemotherapy or radiation therapy.
    Fowler JE; Sesterhenn IA; Mostofi FK
    Urology; 1989 Jan; 33(1):74-7. PubMed ID: 2463705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary.
    Géczi L; Gomez F; Bak M; Bodrogi I
    J Cancer Res Clin Oncol; 2003 May; 129(5):309-15. PubMed ID: 12748851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of prognostic subgroups among patients with metastatic 'IGCCCG poor-prognosis' germ-cell cancer: an explorative analysis using cart modeling.
    Kollmannsberger C; Nichols C; Meisner C; Mayer F; Kanz L; Bokemeyer C
    Ann Oncol; 2000 Sep; 11(9):1115-20. PubMed ID: 11061604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.